HK

Hyun Kim

Vice President at HealthQuest Capital

Houston, Texas

Overview

Work Experience

HC

HealthQuest Capital

  • Vice President

    2022 - Current

    Healthcare growth equity fund focused on medical products, devices, diagnostics, consumer health, healthcare services, and healthcare IT

HR

HealthCare Royalty Partners

  • Senior Associate

    2017 - 2022

    Special situations investing in commercial or near commercial biopharma companies or products; involved in 7 deals with cumulative deal value >$1B. Notable deals include Shingrix (GSK), Zolgensma (Novartis), and Krystexxa (Horizon Therapeutics).

LP

Leerink Partners

  • Investment Banking Analyst

    2016 - 2017

    Biopharma investment banking, advising on M&A, licensing deals, and capital raises for emerging biotech companies. Notable deals include Intellia Therapeutics (NTLA), Beigene (BGNE), Vericel (VCEL), and Dermira (DERM).

P

Philips

  • Finance Accounting Intern

    2015 - 2015

    Part-time FP&A role within Invivo Corporation, a subsidiary of Philips Healthcare that focuses on manufacturing MRI coils

GH

GE Healthcare

  • Sales Representative

    2015 - 2015

    Part-time door-to-door lab equipment sales at the University of Florida campus

HC

HealthQuest Capital

  • Intern

    2013 - 2014

    Intern at HealthQuest

GC

GE Capital

  • FMP Analyst Intern

    2014 - 2014

    Intern in the Healthcare Financial Services division, which focused on lending to healthcare real estate entities (e.g. SNFs, NFs, and ALFs)

Education

Relevant Websites